125 related articles for article (PubMed ID: 38934648)
21. Distributions of hydroperoxide positional isomers generated by oxidation of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine in liposomes and in methanol solution.
Wang XH; Ushio H; Ohshima T
Lipids; 2003 Jan; 38(1):65-72. PubMed ID: 12669821
[TBL] [Abstract][Full Text] [Related]
22. Hypericin photodynamic activity in DPPC liposomes - part II: stability and application in melanoma B16-F10 cancer cells.
de Morais FAP; Gonçalves RS; Vilsinski BH; Lazarin-Bidóia D; Balbinot RB; Tsubone TM; Brunaldi K; Nakamura CV; Hioka N; Caetano W
Photochem Photobiol Sci; 2020 May; 19(5):620-630. PubMed ID: 32248218
[TBL] [Abstract][Full Text] [Related]
23. A single photodynamic priming protocol augments delivery of ⍺-PD-L1 mAbs and induces immunogenic cell death in head and neck tumors.
Bhandari C; Moffat A; Fakhry J; Malkoochi A; Nguyen A; Trinh B; Hoyt K; Story MD; Hasan T; Obaid G
Photochem Photobiol; 2023 Oct; ():. PubMed ID: 37818742
[TBL] [Abstract][Full Text] [Related]
24. In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications.
Hua S; Vaughan B
Int J Nanomedicine; 2019; 14():2191-2206. PubMed ID: 30988616
[TBL] [Abstract][Full Text] [Related]
25. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy.
Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M
Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944
[TBL] [Abstract][Full Text] [Related]
26.
Zhu TC; Kim MM; Liang X; Finlay JC; Busch TM
Photonics Lasers Med; 2015 Feb; 4(1):59-71. PubMed ID: 25927018
[TBL] [Abstract][Full Text] [Related]
27. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
[TBL] [Abstract][Full Text] [Related]
28. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
[TBL] [Abstract][Full Text] [Related]
29. A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer.
Mir Y; Elrington SA; Hasan T
Nanomedicine; 2013 Oct; 9(7):1114-22. PubMed ID: 23485748
[TBL] [Abstract][Full Text] [Related]
30. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
[TBL] [Abstract][Full Text] [Related]
31. Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line.
Erdem SS; Obeidin VA; Yigitbasi T; Tumer SS; Yigit P
J Photochem Photobiol B; 2018 Jun; 183():266-274. PubMed ID: 29747146
[TBL] [Abstract][Full Text] [Related]
32. Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells.
Baglo Y; Liang BJ; Robey RW; Ambudkar SV; Gottesman MM; Huang HC
Cancer Lett; 2019 Aug; 457():110-118. PubMed ID: 31071369
[TBL] [Abstract][Full Text] [Related]
33. High-Throughput
Hamilton AG; Swingle KL; Thatte AS; Mukalel AJ; Safford HC; Billingsley MM; El-Mayta RD; Han X; Nachod BE; Joseph RA; Metzloff AE; Mitchell MJ
ACS Nano; 2024 Jun; 18(25):16151-16165. PubMed ID: 38861479
[TBL] [Abstract][Full Text] [Related]
34. Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels.
Ichikawa K; Hikita T; Maeda N; Yonezawa S; Takeuchi Y; Asai T; Namba Y; Oku N
Biochim Biophys Acta; 2005 May; 1669(1):69-74. PubMed ID: 15843001
[TBL] [Abstract][Full Text] [Related]
35. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
[TBL] [Abstract][Full Text] [Related]
36. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
37. A Formulation Study of 5-Aminolevulinic Encapsulated in DPPC Liposomes in Melanoma Treatment.
Lin MW; Huang YB; Chen CL; Wu PC; Chou CY; Wu PC; Hung SY
Int J Med Sci; 2016; 13(7):483-9. PubMed ID: 27429584
[TBL] [Abstract][Full Text] [Related]
38. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
Thomas AM; Kapanen AI; Hare JI; Ramsay E; Edwards K; Karlsson G; Bally MB
J Control Release; 2011 Mar; 150(2):212-9. PubMed ID: 21094191
[TBL] [Abstract][Full Text] [Related]
39. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
Gross N; Ranjbar M; Evers C; Hua J; Martin G; Schulze B; Michaelis U; Hansen LL; Agostini HT
Mol Vis; 2013; 19():54-61. PubMed ID: 23335851
[TBL] [Abstract][Full Text] [Related]
40. Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy.
Kim J; Song S; Gwak M; Cho H; Yun WS; Hwang N; Kim J; Lee JS; Kim DH; Kim H; Jeon SI; Kim TI; Kim K
Biomater Res; 2023 Oct; 27(1):102. PubMed ID: 37845762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
